Bioinformatics Market worth $34.41 billion by 2031 - Exclusive Report by MarketsandMarkets™

According to the company, the Bioinformatics Market is projected to grow from USD 18.63 billion in 2026 to reach USD 34.41 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.1% during the forecast period.

In 2025, North America accounted for the largest share of the global bioinformatics market, at 42.2%. The bioinformatics services segment is expected to register the highest CAGR of 14.8% during the forecast period. Drug discovery and development held the largest share of the bioinformatics market, at 34.0% in 2025.

Key players in the bioinformatics market include Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN N.V., and Agilent Technologies, Inc., known for their significant market share. Emerging companies such as DEEP GENOMICS and DNASTAR are gaining recognition for their contributions in specialized niche areas.

The market's growth is fueled by increased adoption of next-generation sequencing (NGS) technology, substantial funding for genomics and precision medicine, and a rising demand for efficient analysis of large-scale biological data. The integration of bioinformatics tools in pharmaceutical and biotech firms and other research organizations is enhancing research efficiency and clinical decision-making.

The Asia Pacific region is anticipated to register the highest growth rate during the forecast period, driven by a rising demand for precision medicine and advancements in next-generation sequencing technology. Significant investments in genomic research and healthcare technology are being made by countries such as China, India, Japan, South Korea, and Singapore.